The dopamine transporter is a sodium-dependent reuptake carrier that is suspected to play a role in such neurologic and psychiatric disorders as Parkinson’s disease, Tourette’s disease, schizophrenia, and addiction. It is a12-transmembrane domain transporter with the N- and C- terminus regions located within the cytoplasm. This antibody to the dopamine transporter was originally designated DAT/e2 and is now termed anti-DAT-ECD, emphasizing that it recognizes an extracellular domain.
This antibody recognizes the second extracellular loop of the dopamine transporter (DAT-ECD) in rat and human. It was produced in rat by immunization with a GST-DAT-loop fusion protein, then construction of a hybridoma with the murine nonsecreting myeloma cell line Sp2/0. The second extracellular loop, consisting of amino acids 180-218, was used to construct the fusion protein. It has been conjugated to biotin via an amide bond.
Applications include immunocytochemistry, immunohistochemistry, and immunoblotting.
Other Dopamine Transporter Products:
Dopamine Transporter Rat Monoclonal (DAT-ECD) (Cat. #AB-N17) | Alexa488-labeled (Cat. #AB-N17FLA) | biotin-labeled (Cat. #AB-N17BT) | FITC-labeled (Cat. #AB-N17FL)
Dopamine Transporter Rat Monoclonal (DAT-NT) (Cat. #AB-N18) | Alexa488-labeled (Cat. #AB-N18FLA) | biotin-labeled (Cat. #AB-N18BT)